Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients

Archive ouverte

Di Buduo, Christian | Laurent, Pierre-Alexandre | Zaninetti, Carlo | Lordier, Larissa | Soprano, Paolo | Ntai, Aikaterini | Barozzi, Serena | La Spada, Alberto | Biunno, Ida | Raslova, Hana | Bussel, James | Kaplan, David | Balduini, Carlo | Pecci, Alessandro | Balduini, Alessandra

Edité par CCSD ; eLife Sciences Publication -

International audience. Thrombocytopenic disorders have been treated with the Thrombopoietin-receptor agonist Eltrombopag. Patients with the same apparent form of thrombocytopenia may respond differently to the treatment. We describe a miniaturized bone marrow tissue model that provides a screening bioreactor for personalized, pre-treatment response prediction to Eltrombopag for individual patients. Using silk fibroin, a 3D bone marrow niche was developed that reproduces platelet biogenesis. Hematopoietic progenitors were isolated from a small amount of peripheral blood of patients with mutations in ANKRD26 and MYH9 genes, who had previously received Eltrombopag. The ex vivo response was strongly correlated with the in vivo platelet response. Induced Pluripotent Stem Cells (iPSCs) from one patient with mutated MYH9 differentiated into functional megakaryocytes that responded to Eltrombopag. Combining patient-derived cells and iPSCs with the 3D bone marrow model technology allows having a reproducible system for studying drug mechanisms and for individualized, pre-treatment selection of effective therapy in Inherited Thrombocytopenias.

Consulter en ligne

Suggestions

Du même auteur

Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseases

Archive ouverte | Balduini, Alessandra | CCSD

International audience

Increased RhoA pathway activation downstream of αIIbβ3/SRC contributes to heterozygous Bernard Soulier syndrome

Archive ouverte | Lordier, Larissa | CCSD

International audience. Bernard Soulier Syndrome (BSS) is a severe bleeding disorder with moderate to severe thrombocytopenia, giant platelets, and platelet dysfunction, caused by biallelic mutations in GP1BA, GP1BB...

Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms

Archive ouverte | Di Buduo, Christian | CCSD

International audience. Abstract Approximately one-fourth of patients with essential thrombocythemia or primary myelofibrosis carry a somatic mutation of the calreticulin gene (CALR), the gene encoding for calreticu...

Chargement des enrichissements...